121 related articles for article (PubMed ID: 23705495)
1. [Mesenchymal stem cells as an antitumor therapy tool].
Karshieva SSh; Krasikov LS; Beliavskiĭ AV
Mol Biol (Mosk); 2013; 47(1):50-60. PubMed ID: 23705495
[TBL] [Abstract][Full Text] [Related]
2. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
[TBL] [Abstract][Full Text] [Related]
3. Stem and progenitor cell-mediated tumor selective gene therapy.
Aboody KS; Najbauer J; Danks MK
Gene Ther; 2008 May; 15(10):739-52. PubMed ID: 18369324
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells: A new platform for targeting suicide genes in cancer.
Moradian Tehrani R; Verdi J; Noureddini M; Salehi R; Salarinia R; Mosalaei M; Simonian M; Alani B; Ghiasi MR; Jaafari MR; Mirzaei HR; Mirzaei H
J Cell Physiol; 2018 May; 233(5):3831-3845. PubMed ID: 28703313
[TBL] [Abstract][Full Text] [Related]
5. Stem cell based cancer gene therapy.
Cihova M; Altanerova V; Altaner C
Mol Pharm; 2011 Oct; 8(5):1480-7. PubMed ID: 21755953
[TBL] [Abstract][Full Text] [Related]
6. Polylysine-modified polyethylenimine polymer can generate genetically engineered mesenchymal stem cells for combinational suicidal gene therapy in glioblastoma.
Malik YS; Sheikh MA; Xing Z; Guo Z; Zhu X; Tian H; Chen X
Acta Biomater; 2018 Oct; 80():144-153. PubMed ID: 30223091
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells as cellular vehicles for prodrug gene therapy against tumors.
Amara I; Touati W; Beaune P; de Waziers I
Biochimie; 2014 Oct; 105():4-11. PubMed ID: 24977933
[TBL] [Abstract][Full Text] [Related]
8. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
[TBL] [Abstract][Full Text] [Related]
9. IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand.
Du J; Zhou L; Chen X; Yan S; Ke M; Lu X; Wang Z; Yu W; Xiang AP
Int J Biochem Cell Biol; 2012 Aug; 44(8):1305-14. PubMed ID: 22554587
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression.
Abrate A; Buono R; Canu T; Esposito A; Del Maschio A; Lucianò R; Bettiga A; Colciago G; Guazzoni G; Benigni F; Hedlund P; Altaner C; Montorsi F; Cavarretta IT
Eur J Cancer; 2014 Sep; 50(14):2478-88. PubMed ID: 25060826
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells: an emerging tool for cancer targeting and therapy.
Fritz V; Jorgensen C
Curr Stem Cell Res Ther; 2008 Jan; 3(1):32-42. PubMed ID: 18220921
[TBL] [Abstract][Full Text] [Related]
12. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
13. Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1/CCR2 axis and exhibit antitumor effects.
Yan C; Song X; Yu W; Wei F; Li H; Lv M; Zhang X; Ren X
Tumour Biol; 2016 Jun; 37(6):8425-35. PubMed ID: 26733169
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
[TBL] [Abstract][Full Text] [Related]
15. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
Uchibori R; Okada T; Ito T; Urabe M; Mizukami H; Kume A; Ozawa K
J Gene Med; 2009 May; 11(5):373-81. PubMed ID: 19274675
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection.
Hu YL; Huang B; Zhang TY; Miao PH; Tang GP; Tabata Y; Gao JQ
Mol Pharm; 2012 Sep; 9(9):2698-709. PubMed ID: 22862421
[TBL] [Abstract][Full Text] [Related]
17. In vivo magnetic resonance imaging of cell tropism, trafficking mechanism, and therapeutic impact of human mesenchymal stem cells in a murine glioma model.
Chien LY; Hsiao JK; Hsu SC; Yao M; Lu CW; Liu HM; Chen YC; Yang CS; Huang DM
Biomaterials; 2011 Apr; 32(12):3275-84. PubMed ID: 21295344
[TBL] [Abstract][Full Text] [Related]
18. Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma.
Altanerova V; Cihova M; Babic M; Rychly B; Ondicova K; Mravec B; Altaner C
Int J Cancer; 2012 May; 130(10):2455-63. PubMed ID: 21732344
[TBL] [Abstract][Full Text] [Related]
19. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
[TBL] [Abstract][Full Text] [Related]
20. TRAIL based therapy: overview of mesenchymal stem cell based delivery and miRNA controlled expression of TRAIL.
Attar R; Sajjad F; Qureshi MZ; Tahir F; Hussain E; Fayyaz S; Farooqi AA
Asian Pac J Cancer Prev; 2014; 15(16):6495-7. PubMed ID: 25169476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
